CLARITY F2F Meeting 10 October 2024
The first CLARITY consortium meeting (Utrecht, the Netherlands, Oct 9-10 2024) is a wrap! ๐
Partners from Germany, Spain, Germany Estonia and the Netherlands, as well as the international RSV Patient Network came to meet and discuss research in CLARITY (Causative Link between respirAtory syncytial viRus and chronic respiratory diseases: Identifying Targets for therapY). We started the meeting with a poignant story from an RSV infant patient who is now 5 years old, explained wonderfully by his mother Brenda van Voorthuizen. CLARITY consortium consists of Marianne Boes (UMC Utrecht, coordinator ๐ณ๐ฑ), Marleen Van Ampting, PhD, (UMC Utrecht, manager ๐ณ๐ฑ), with Louis Bont (UMC Utrecht, ๐ณ๐ฑ), Pascal Falter-Braun (Helmholtz Munich ๐ฉ๐ช ), Claudia Falter (Helmholtz Munich ๐ฉ๐ช ), Patrick Aloy (IRB Barcelona ๐ช๐ธ ), Inmaculada Casas (Instituto de Salud Carlos III ๐ช๐ธ ), @Cristina Calvo ๐ช๐ธ , Marรญa de la Montaรฑa Iglesias Caballero (Servicio madrileรฑo de salud (SERMAS) ๐ช๐ธ ), Erik Abner (University of Tartu ๐ช๐ช ), Daan Pieren, Sonja Rittchen, Leyla Kragten-Tabatabaie, Lies Kriek and Isabelle Phijffer (ReSViNET | Respiratory Syncytial Virus (RSV) Foundation ๐ ). UMC Utrecht leads the international consortium that will run for five years, funded by a HORIZON HLTH 2023 grant from the European Commission of โฌ 7.1 million. European Health and Digital Executive Agency (HaDEA), Horizon Europe CLARITY project EU